等待开盘 11-19 09:30:00 美东时间
+1.410
+23.31%
今日重点评级关注:康托·菲茨杰拉德:维持Lexeo Therapeutics"超配"评级,目标价从23美元升至37美元;摩根士丹利:维持Sana Biotechnology"超配"评级,目标价从12美元升至13美元
11-17 17:31
Baird analyst Andrew Wittmann maintains Suncrete (NASDAQ:RMIX) with a Outperform and lowers the price target from $17 to $9.
11-16 20:22
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 财务业绩:- **营收**:第三季度营收1.41亿美元,环比增长45%,同比增长163%。本季度首次完整计入此前所有已完成收购的贡献。有机增长约10%,其中约三分之二来自销量,约三分之一来自价格。预拌混凝土销量环比增长32%,同比增长125%。 - **GAAP净利润**:净利润约7.8万美元(CFO口述为7.6万美元,后更正为7.8万美元)。上一季度(2026年第二季度)为净亏损3,710万美元,上年同期为净利润460万美元。 - **Non-GAAP利润**: - 调整后EBITDA为2,240万美元,利润率15.9%。 - 补充调整后E
11-14 12:04
Suncrete (NASDAQ:RMIX) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.08 by 112.5 percent. The company reported quarterly sales of $141.000 million which missed the analyst consensus estimate of $146.078 million by 3.48 percent.
11-13 21:02
Suncrete (NASDAQ:RMIX) lowers FY2026 sales outlook from $420.000 million-$480.000 million to $408.000 million-$434.000 million vs $443.298 million estimate.
11-13 21:01
Revenue Up 163% Compared to Q3 2025 and Up 45% Compared to Q2 2026 TULSA, Okla., Nov. 13, 2026 /PRNewswire/ -- Suncrete, Inc. (NASDAQ: RMIX) (the "Company"), a ready-mix concrete logistics a...
11-13 21:00
Suncrete, Inc. (NASDAQ:RMIX) will release its third quarter earnings report before the opening bell on Friday, Nov. 13. Analysts expect the Tulsa, Oklahoma-based company to report quarterly earnings of 8 cents per share, on revenue of $146.19 million, according to Benzinga Pro. On Aug. 14, Suncrete ...
11-13 15:17
Mitsubishi UFJ Financial Group headlines Friday’s reports as investors assess whether Japan’s major banks can extend a strong year for the sector despite recent pullbacks. Sumitomo Mitsui, Mizuho Financial, Suncrete, SBC Medical Group, GRAVITY, Eagle Point Credit, Digi Power X, Eagle Point Income an...
11-13 04:30
今日重点评级关注:Ascendiant Capital:维持Alzamend Neuro"买入"评级,目标价从25美元升至26美元;Tigress Financial:维持Legence"买入"评级,目标价从125美元升至130美元
08-20 08:39
B. Riley Securities analyst Rohit Seth reiterates Suncrete (NASDAQ:RMIX) with a Buy and lowers the price target from $26 to $25.
08-19 21:41